Back to top

Lisata Therapeutics (LSTA) Terminates Merger Agreement with Kuva Labs Amid Financing Issues

Lisata Therapeutics (LSTA) Terminates Merger Agreement with Kuva Labs Amid Financing Issues

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Lisata Therapeutics, Inc. (LSTA)